Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc.

ESTA · Nasdaq

Establishment Labs Holdings Inc. (ESTA) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Establishment Labs Holdings Inc. in 2026. The next earnings report is expected on November 10, 2026.

Earnings calendar

Next earnings date

10 Nov 2026

In 82 days

EPS estimate

-0.28

Revenue estimate

65.9M

Past earnings

06 Aug 2026
EPS actual
-0.39 (-15.8%)
estimate -0.34
Revenue actual
67.5M (+2.7%)
estimate 65.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
06 May 2026
EPS actual
-0.45 (-26.8%)
estimate -0.35
Revenue actual
59.9M (+4.3%)
estimate 57.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
24 Feb 2026
EPS actual
-0.09 (+59.5%)
estimate -0.22
Revenue actual
64.6M (+1.2%)
estimate 63.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Establishment Labs Holdings Inc. missed consensus estimates for EPS but exceeded revenue expectations, with EPS of -$0.39 versus an expected -$0.3368 and revenue of $67.54 million exceeding estimates by 2.7%. In the prior quarter EPS also missed expectations while revenue came in ahead of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Sector
Healthcare
Industry
Medical devices
Country
Costa Rica
Exchange
Nasdaq
CEO
Fillipo Peter Caldini
Employees
1,034
IPO date
19 Jul 2018
ISIN
VGG312491084
Website
establishmentlabs.com

Frequently asked questions

When does Establishment Labs Holdings Inc. (ESTA) next report earnings?

Establishment Labs Holdings Inc. (ESTA) is scheduled to report earnings on November 10, 2026.

What was Establishment Labs Holdings Inc.'s most recent earnings date?

Establishment Labs Holdings Inc. (ESTA) last reported earnings on August 6, 2026.

Where is Establishment Labs Holdings Inc. stock listed?

Establishment Labs Holdings Inc. (ESTA) is listed on Nasdaq.